A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission

Digestion
J Powell-TuckJ E Lennard-Jones

Abstract

A double-blind crossover trial compared prednisolone, 40 mg given orally on alternate days, with placebo as a maintenance treatment for ulcerative colitis in remission. In each patient, the study was over two periods of 3 months. Of 24 patients who completed both periods, 11 relapsed while taking placebo but not while taking prednisolone, and 1 relapsed on prednisolone but did not on placebo (p less than 0.01). 1 patient had to stop prednisolone because of hyperglycaemia; other side effects noted were mild. Prednisolone, cautiously used in this way, could be justified for the few patients who relapse frequently despite sulphasalazine.

Citations

Feb 1, 1996·Pediatric Clinics of North America·B S Kirschner
Mar 22, 2002·Journal of Clinical Gastroenterology·Seymour Katz
Jan 1, 1997·Inflammatory Bowel Diseases·L R SutherlandUNKNOWN Task Force on Clinical Trials of the International Organisation for the Study of Inflammatory Bowel Disease
Mar 4, 2000·Inflammatory Bowel Diseases·D H Present
Jun 10, 2011·Current Opinion in Gastroenterology·Wojciech BlonskiGary R Lichtenstein
Dec 1, 1994·Journal of Internal Medicine·H O Conn, T Poynard
Jul 4, 1992·BMJ : British Medical Journal·M A Kamm, A Senapati
Jun 1, 1991·Gut·M C de KaskiH J Hodgson
Nov 1, 1984·Postgraduate Medical Journal·J E Lennard-Jones
Mar 10, 2010·Journal of Gastroenterology·Matthias A Engel, Markus F Neurath
Sep 5, 2007·Alimentary Pharmacology & Therapeutics·G Bianchi PorroS Ardizzone
Mar 10, 2015·Gastroenterology·Brian BresslerUNKNOWN Toronto Ulcerative Colitis Consensus Group
Aug 11, 1992·The American Journal of Medicine·D L Geier, P B Miner
Jan 11, 2017·The American Journal of Gastroenterology·William D CheySteven F Moss
Feb 13, 2018·Journal of Gastroenterology·Katsuyoshi MatsuokaTooru Shimosegawa
Nov 29, 2013·Current Opinion in Gastroenterology·Wojciech BlonskiGary R Lichtenstein
Oct 1, 1993·Alimentary Pharmacology & Therapeutics·M Carpani de Kaski, H J Hodgson
Jan 22, 2013·Expert Opinion on Pharmacotherapy·Sotirios D GeorgopoulosStylianos Karatapanis
Dec 1, 1989·DICP : the Annals of Pharmacotherapy·R F SottileB Mehl
Nov 6, 1998·The Medical Journal of Australia·P R Gibson, R P Anderson
Apr 23, 2021·Journal of Gastroenterology·Hiroshi NakaseKazuhiko Koike

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.